HCPLive

Medical News

Daily news and information for physicians in a range of specialties and practice settings.

Latest Medical News

Factor Investing Proves Useful to Some
Factor Investing Proves Useful to Some
What should the building blocks of a portfolio be – sectors or factors? This sounds an annoyingly abstract and philosophical question, but it is at the heart of the way equity management is being rebuilt post-crisis.
Simple Request Turns Into Cautionary Tale of Airline Customer Service Woes
It seemed like a simple request, but it turned out to be one with as many answers as there were airline service people handling our calls.
FDA Approves New Rosacea Foam Treatment
The US Food and Drug Administration (FDA) today approved azelaic acid (Finacea Foam/Bayer) 15% for the treatment of inflammatory papules and pustules of mild-to-moderate rosacea.
Novel Knee Osteoarthritis Treatment for Obese Patients
A new gait training device has been shown to significantly improve clinical symptoms in obese patients with knee osteoarthritis (OA).
Balance Problems for Multiple Sclerosis Patients Come from T Cells
Balance issues for multiple sclerosis patients may be caused by T cells malfunctioning, according to findings published in Immunity.
Stem Cell Treatment Shows Promise in Animal Model of Diabetic Neuropathy
Study shows intramuscular injected bone marrow-derived mesenchymal stem cells may be able to restore the myelin sheath and nerve cells in diabetic sciatic nerves.
Thai Study Identifies Predictive Factors behind Deadly Skin Disease
Among dermatologic conditions, necrotizing fasciitis (NF)—a potentially life-threatening infection of the skin and fascia—is notorious and nefarious. While it is not common in developed countries, NF has a high prevalence in undeveloped countries. Immediate treatment is essential, and thus, so is immediate and accurate diagnosis.

Product News

Combo Cystic Fibrosis Therapy Approved
Combo Cystic Fibrosis Therapy Approved
The US Food and Drug Administration (FDA) on Thursday approved Orkambi (lumacaftor/ivacaftor/Vertex) to treat cystic fibrosis patients age 12 and older with two copies of the F508del mutation in the CFTR gene.
Hepatitis C: Good News on Genotype 1b Drug Combo
Results from the Turquoise III trial show an antiviral combo cured patients with chronic hepatitis C genotype 1b infections, according to data to be released June 26 at the International Symposium on Viral Hepatitis and Liver Diseases in Berline, Germany.
New Antiplatelet Drug Approved
The US Food and Drug Administration today approved the use of cangrelor (Kengreal/The Medicines Company) for adults undergoing percutaneous coronary interventions (PCI).
Brain Implant for Parkinson’s Disease Approved
The US Food and Drug Administration (FDA) granted approval for the Brio Neurostimulation System– the second brain implant stimulation device to aid in the reduction of Parkinson’s disease symptoms and essential tremor.
FDA Approves Toddler Use for Seizure Drug
The FDA extended the use of toparimate, an anti-seizure drug, to children as young as 2.

Most Popular

$vacMongoViewPlus$ $vAR$